- 全部删除
您的购物车当前为空
PLK1/BRD4-IN-5 (Compound SC10) 是一种口服活性的PLK1和BRD4抑制剂,针对PLK1和BRD4的IC50分别为0.3 nM和60.8 nM。它能够诱导MV4-11细胞在S期阻滞,并以剂量依赖性引发凋亡 (apoptosis)。PLK1/BRD4-IN-5 可用于癌症研究。
PLK1/BRD4-IN-5 (Compound SC10) 是一种口服活性的PLK1和BRD4抑制剂,针对PLK1和BRD4的IC50分别为0.3 nM和60.8 nM。它能够诱导MV4-11细胞在S期阻滞,并以剂量依赖性引发凋亡 (apoptosis)。PLK1/BRD4-IN-5 可用于癌症研究。

PLK1/BRD4-IN-5 相关产品
| 产品描述 | PLK1/BRD4-IN-5 (Compound SC10) is an orally active inhibitor of PLK1 and BRD4, exhibiting IC50 values of 0.3 nM and 60.8 nM, respectively. It induces S phase cell cycle arrest and dose-dependent apoptosis in MV4-11 cells. PLK1/BRD4-IN-5 is useful for cancer research. |
| 靶点活性 | PLK1:0.3 nM, BRD4:60.8 nM |
| 体外活性 | PLK1/BRD4-IN-5 (Compound SC10) 在三种肿瘤细胞系中表现出显著的抗增殖活性 (MDA-MB-231 IC 50 = 17.3 nM, MDA-MB-361 IC 50 = 8.4 nM, MV4-11 IC 50 = 5.4 nM)。 |
| 分子式 | C31H44N8O3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容